The global cholera vaccine market was valued at USD 93.9 million in 2024 and is projected to reach USD 163.4 million by 2030, expanding at a healthy CAGR of 10.0% from 2025 to 2030. Cholera, caused by Vibrio cholerae, continues to be a major public health threat in endemic regions, particularly where access to clean water and proper sanitation is limited. Vaccines have become a critical...